Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Immune checkpoint inhibitors in acute myeloid leukemia
Naval Daver
Leukemia
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immune checkpoint inhibitors in acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Acute Myeloid Leukemia
100%
cyclopropapyrroloindole
81%
pembrolizumab
36%
Nivolumab
35%
Hematologic Diseases
30%
Anti-Idiotypic Antibodies
22%
Steroids
19%
Macrophages
18%
Therapeutics
17%
Biomarkers
17%
T-Lymphocytes
16%
Infections
12%
Population
10%
Chemistry
Biological Marker
94%
Environment
59%